[Federal Register Volume 86, Number 29 (Tuesday, February 16, 2021)]
[Notices]
[Pages 9522-9523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03047]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on March 3, 2021. The topic for this 
meeting will be ``COVID-19 and Diabetes.'' The meeting is open to the 
public.

DATES: The meeting will be held on March 3, 2021 from 12 noon to 4:00 
p.m. EST.

ADDRESSES: The meeting will be held via the online video conferencing--
Zoom. For details, and to register, please contact [email protected].

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, including a draft agenda, see the DMICC website, 
www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive 
Secretary of the Diabetes Mellitus Interagency Coordinating Committee, 
National Institute of Diabetes and Digestive and Kidney Diseases, 31 
Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-
2560, telephone: 301-496-6623; FAX: 301-480-6741; email: 
[email protected].

SUPPLEMENTARY INFORMATION: In accordance with 42 U.S. Code 285c-3, the 
DMICC, chaired by the National Institute of Diabetes and Digestive and 
Kidney Diseases (NIDDK) comprising members of the Department of Health 
and Human Services and other federal agencies that support diabetes-
related activities, facilitates cooperation, communication, and 
collaboration on diabetes among government entities. DMICC meetings, 
held several times a year, provide an opportunity for Committee members 
to learn about and discuss current and future diabetes programs in 
DMICC member organizations and to identify opportunities for 
collaboration. The March 3, 2021 DMICC meeting will focus on ``COVID-19 
and Diabetes.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC website, www.diabetescommittee.gov.


[[Page 9523]]


    Dated: February 4, 2021.
Bruce Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2021-03047 Filed 2-12-21; 8:45 am]
BILLING CODE 4140-01-P